Results 12,721-12,740 of 49,836 for speaker:Stephen Donnelly

Written Answers — Department of Health: Hospital Data (2 Dec 2020)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond directly to the Deputy, as soon as possible.

Written Answers — Department of Health: Hospital Data (2 Dec 2020)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond directly to the Deputy, as soon as possible.

Written Answers — Department of Health: Hospital Appointments Status (2 Dec 2020)

Stephen Donnelly: It is recognised that waiting times for scheduled appointments and procedures have been impacted as a direct result of the COVID-19 pandemic. In response to the Covid-19 pandemic the HSE had to take measures to defer most scheduled care activity in March, April, and May of this year. This was to ensure patient safety and that all appropriate resources were made available for Covid-19...

Written Answers — Department of Health: Hospital Appointments Status (2 Dec 2020)

Stephen Donnelly: It is recognised that waiting times for scheduled appointments and procedures have been impacted as a direct result of the COVID-19 pandemic. In response to the Covid-19 pandemic the HSE had to take measures to defer most scheduled care activity in March, April, and May of this year. This was to ensure patient safety and that all appropriate resources were made available for Covid-19...

Written Answers — Department of Health: Nursing Staff (2 Dec 2020)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond directly to the Deputy, as soon as possible.

Written Answers — Department of Health: Nursing Staff (2 Dec 2020)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond directly to the Deputy, as soon as possible.

Written Answers — Department of Health: Nursing Education (2 Dec 2020)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond directly to the Deputy, as soon as possible.

Written Answers — Department of Health: Medicinal Products (2 Dec 2020)

Stephen Donnelly: As the particular issue raised relates to an individual case, I have arranged for the question to be referred to the HSE for direct reply to the Deputy.

Written Answers — Department of Health: Audiology Services (2 Dec 2020)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Written Answers — Department of Health: Covid-19 Pandemic (2 Dec 2020)

Stephen Donnelly: Resilience and Recovery 2020-2021: Plan for Living with COVID-19 was published by the Government on 15 September 2020. This Framework sets out Ireland's approach to managing and living with COVID-19 in a range of areas over the next 6 - 9 months. The plan sets out five levels of response, each with a number of measures designed to help us all lower COVID-19 transmission and setting out...

Written Answers — Department of Health: Medicinal Products (2 Dec 2020)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Written Answers — Department of Health: National Treatment Purchase Fund (2 Dec 2020)

Stephen Donnelly: The National Treatment Purchase Fund (NTPF) has advised my Department that they are unable to provide average wait times by county for patients referred under the National Treatment Purchase Scheme. It is important to note that the NTPF works with public hospitals, as opposed to with patients directly, to offer and provide the funding for treatment to clinically suitable long waiting...

Written Answers — Department of Health: Cross-Border Health Initiatives (2 Dec 2020)

Stephen Donnelly: I propose to take Questions Nos. 172 and 173 together. The UK’s withdrawal from the EU has implications for healthcare arrangements that currently operate under the EU legislative framework, including those arrangements covered by the Cross Border Directive (CBD). With effect from 1 January 2021, the provisions of the CBD will no longer apply to the UK. My officials are giving...

Written Answers — Department of Health: Rare Diseases (2 Dec 2020)

Stephen Donnelly: Following a request from the HSE Drugs Group, the HSE Rare Diseases Medicinal Products Technology Review Committee convened on 24 September to engage with patients and clinicians in the assessment of two drugs. These are: 1. Burosumab (Crysvita®) for the treatment of X-linked hypophosphataemia with radiographic evidence of bone disease in children 1 year of age and older and adolescents...

Written Answers — Department of Health: Medical Aids and Appliances (2 Dec 2020)

Stephen Donnelly: Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Written Answers — Department of Health: Treatment Benefit Scheme (2 Dec 2020)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Select Committee on Health: Estimates for Public Services 2020
Vote 38 - Department of Health (Supplementary) (2 Dec 2020)

Stephen Donnelly: I thank the select committee for the opportunity to bring this Supplementary Estimate for Vote 38 before it today. I apologise to colleagues for not being available earlier today, as the committee had requested. I was attending a meeting of EU health Ministers, an annual meeting. It was quite long, but it included matters such as a briefing on Covie-19 vaccines so, regrettably, I could not...

Select Committee on Health: Estimates for Public Services 2020
Vote 38 - Department of Health (Supplementary) (2 Dec 2020)

Stephen Donnelly: Yes, my understanding is that it does. I do not want to eat into the Deputy's time but I could give him the number of millions of doses for each of the five or six vaccines we have.

Select Committee on Health: Estimates for Public Services 2020
Vote 38 - Department of Health (Supplementary) (2 Dec 2020)

Stephen Donnelly: AstraZeneca’s vaccine is the first one, of which we have 3.3 million doses. We have 2.2 million doses from Janssen, 3.3 million from Sanofi and 2.3 million doses from Pfizer. From Moderna we have 875,000 doses. The sixth vaccine is from CureVac. For the first five companies, we are signed up to the advance purchase agreement and those are the initial doses Ireland will get from...

Select Committee on Health: Estimates for Public Services 2020
Vote 38 - Department of Health (Supplementary) (2 Dec 2020)

Stephen Donnelly: My understanding is that we are locked in. The mechanism in which the EU is engaged is the advance purchase agreement, which essentially helps with the incentive for the companies.